New TB cocktail shows promise in early trial
NCT ID NCT04550832
First seen Oct 31, 2025 · Last updated May 20, 2026 · Updated 31 times
Summary
This study tested a new drug called delpazolid, given with three standard TB medicines (bedaquiline, delamanid, moxifloxacin), in 76 adults with newly diagnosed, drug-sensitive pulmonary tuberculosis. The goal was to see if the combination is safe and how the body processes the drug over 16 weeks. Results help determine the best dose for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical HIV Research Unit (CHRU) University of the Witwatersrand
Johannesburg, 2092, South Africa
-
Ifakara Health Institute
Bagamoyo, Tanzania
-
Ki'bongoto Infectious Disease Hospital (KIDH) Kilimanjaro Clinical Research Institute (KCRI)
Moshi, Tanzania
-
National Institute for Medical Research (NIMR-MMRC)
Mbeya, Tanzania
-
The Aurum Institute Tembisa Clinical Research Centre
Tembisa, Gauteng, 1632, South Africa
Conditions
Explore the condition pages connected to this study.